ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 92 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $268,000 | +30.7% | 3,230 | +21.1% | 0.00% | 0.0% |
| Q4 2020 | $205,000 | +425.6% | 2,668 | -74.8% | 0.00% | – |
| Q4 2017 | $39,000 | -15.2% | 10,600 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $46,000 | +170.6% | 10,600 | 0.0% | 0.00% | – |
| Q2 2017 | $17,000 | -15.0% | 10,600 | 0.0% | 0.00% | – |
| Q1 2017 | $20,000 | -83.6% | 10,600 | -36.1% | 0.00% | -100.0% |
| Q3 2016 | $122,000 | +60.5% | 16,587 | +16.5% | 0.00% | 0.0% |
| Q2 2016 | $76,000 | – | 14,237 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |